GPRC5A and pancreatic neoplasm: In conclusion, our experimental data demonstrated that low miR-135b-5p level could affect GPRC5A by KLF4, thus hindering cell malignant phenotypes of pancreatic cancer, but the inhibitory effect could be reversed by overexpressing GPRC5A.